Global Psoriatic Arthritis Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Psoriatic Arthritis Therapeutics market size was valued at US$ 6260.8 million in 2023. With growing demand in downstream market, the Psoriatic Arthritis Therapeutics is forecast to a readjusted size of US$ 11660 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Psoriatic Arthritis Therapeutics market. Psoriatic Arthritis Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psoriatic Arthritis Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psoriatic Arthritis Therapeutics market.
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psoriatic Arthritis Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psoriatic Arthritis Therapeutics market. It may include historical data, market segmentation by Type (e.g., Nonsteroidal Anti-Inflammatory Drug, Disease-Modifying Antirheumatic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psoriatic Arthritis Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psoriatic Arthritis Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psoriatic Arthritis Therapeutics industry. This include advancements in Psoriatic Arthritis Therapeutics technology, Psoriatic Arthritis Therapeutics new entrants, Psoriatic Arthritis Therapeutics new investment, and other innovations that are shaping the future of Psoriatic Arthritis Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psoriatic Arthritis Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Psoriatic Arthritis Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psoriatic Arthritis Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psoriatic Arthritis Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psoriatic Arthritis Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psoriatic Arthritis Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psoriatic Arthritis Therapeutics market.
Market Segmentation:
Psoriatic Arthritis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Psoriatic Arthritis Therapeutics market size was valued at US$ 6260.8 million in 2023. With growing demand in downstream market, the Psoriatic Arthritis Therapeutics is forecast to a readjusted size of US$ 11660 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Psoriatic Arthritis Therapeutics market. Psoriatic Arthritis Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Psoriatic Arthritis Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Psoriatic Arthritis Therapeutics market.
Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Psoriatic Arthritis Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Psoriatic Arthritis Therapeutics market. It may include historical data, market segmentation by Type (e.g., Nonsteroidal Anti-Inflammatory Drug, Disease-Modifying Antirheumatic Drug), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Psoriatic Arthritis Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Psoriatic Arthritis Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Psoriatic Arthritis Therapeutics industry. This include advancements in Psoriatic Arthritis Therapeutics technology, Psoriatic Arthritis Therapeutics new entrants, Psoriatic Arthritis Therapeutics new investment, and other innovations that are shaping the future of Psoriatic Arthritis Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Psoriatic Arthritis Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Psoriatic Arthritis Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Psoriatic Arthritis Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Psoriatic Arthritis Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Psoriatic Arthritis Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Psoriatic Arthritis Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Psoriatic Arthritis Therapeutics market.
Market Segmentation:
Psoriatic Arthritis Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Nonsteroidal Anti-Inflammatory Drug
- Disease-Modifying Antirheumatic Drug
- Biologic Drug
- Enzyme Inhibitor
- Hospitals
- Clinics
- Research Labs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Bayer
- Novartis
- Abbott Laboratories
- Sanofi
- Bristol-Myers Squibb
- Janssen Biotech
- Amgen
- UCB
- AbbVie
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis Therapeutics Market Size 2019-2030
2.1.2 Psoriatic Arthritis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psoriatic Arthritis Therapeutics Segment by Type
2.2.1 Nonsteroidal Anti-Inflammatory Drug
2.2.2 Disease-Modifying Antirheumatic Drug
2.2.3 Biologic Drug
2.2.4 Enzyme Inhibitor
2.3 Psoriatic Arthritis Therapeutics Market Size by Type
2.3.1 Psoriatic Arthritis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Psoriatic Arthritis Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Labs
2.5 Psoriatic Arthritis Therapeutics Market Size by Application
2.5.1 Psoriatic Arthritis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
3 PSORIATIC ARTHRITIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis Therapeutics Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Psoriatic Arthritis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS THERAPEUTICS BY REGIONS
4.1 Psoriatic Arthritis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis Therapeutics by Country (2019-2024)
7.2 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET FORECAST
10.1 Global Psoriatic Arthritis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Psoriatic Arthritis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Psoriatic Arthritis Therapeutics Forecast
10.1.3 APAC Psoriatic Arthritis Therapeutics Forecast
10.1.4 Europe Psoriatic Arthritis Therapeutics Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis Therapeutics Forecast
10.2 Americas Psoriatic Arthritis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Psoriatic Arthritis Therapeutics Market Forecast
10.2.2 Canada Psoriatic Arthritis Therapeutics Market Forecast
10.2.3 Mexico Psoriatic Arthritis Therapeutics Market Forecast
10.2.4 Brazil Psoriatic Arthritis Therapeutics Market Forecast
10.3 APAC Psoriatic Arthritis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Psoriatic Arthritis Therapeutics Market Forecast
10.3.2 Japan Psoriatic Arthritis Therapeutics Market Forecast
10.3.3 Korea Psoriatic Arthritis Therapeutics Market Forecast
10.3.4 Southeast Asia Psoriatic Arthritis Therapeutics Market Forecast
10.3.5 India Psoriatic Arthritis Therapeutics Market Forecast
10.3.6 Australia Psoriatic Arthritis Therapeutics Market Forecast
10.4 Europe Psoriatic Arthritis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Psoriatic Arthritis Therapeutics Market Forecast
10.4.2 France Psoriatic Arthritis Therapeutics Market Forecast
10.4.3 UK Psoriatic Arthritis Therapeutics Market Forecast
10.4.4 Italy Psoriatic Arthritis Therapeutics Market Forecast
10.4.5 Russia Psoriatic Arthritis Therapeutics Market Forecast
10.5 Middle East & Africa Psoriatic Arthritis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Psoriatic Arthritis Therapeutics Market Forecast
10.5.2 South Africa Psoriatic Arthritis Therapeutics Market Forecast
10.5.3 Israel Psoriatic Arthritis Therapeutics Market Forecast
10.5.4 Turkey Psoriatic Arthritis Therapeutics Market Forecast
10.5.5 GCC Countries Psoriatic Arthritis Therapeutics Market Forecast
10.6 Global Psoriatic Arthritis Therapeutics Forecast by Type (2025-2030)
10.7 Global Psoriatic Arthritis Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis Therapeutics Product Offered
11.1.3 Pfizer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Psoriatic Arthritis Therapeutics Product Offered
11.2.3 Bayer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Psoriatic Arthritis Therapeutics Product Offered
11.3.3 Novartis Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Psoriatic Arthritis Therapeutics Product Offered
11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Psoriatic Arthritis Therapeutics Product Offered
11.5.3 Sanofi Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product Offered
11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Psoriatic Arthritis Therapeutics Product Offered
11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Psoriatic Arthritis Therapeutics Product Offered
11.8.3 Amgen Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 UCB
11.9.1 UCB Company Information
11.9.2 UCB Psoriatic Arthritis Therapeutics Product Offered
11.9.3 UCB Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 UCB Main Business Overview
11.9.5 UCB Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Psoriatic Arthritis Therapeutics Product Offered
11.10.3 AbbVie Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Psoriatic Arthritis Therapeutics Market Size 2019-2030
2.1.2 Psoriatic Arthritis Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Psoriatic Arthritis Therapeutics Segment by Type
2.2.1 Nonsteroidal Anti-Inflammatory Drug
2.2.2 Disease-Modifying Antirheumatic Drug
2.2.3 Biologic Drug
2.2.4 Enzyme Inhibitor
2.3 Psoriatic Arthritis Therapeutics Market Size by Type
2.3.1 Psoriatic Arthritis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Psoriatic Arthritis Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Research Labs
2.5 Psoriatic Arthritis Therapeutics Market Size by Application
2.5.1 Psoriatic Arthritis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
3 PSORIATIC ARTHRITIS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Psoriatic Arthritis Therapeutics Market Size Market Share by Players
3.1.1 Global Psoriatic Arthritis Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Psoriatic Arthritis Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PSORIATIC ARTHRITIS THERAPEUTICS BY REGIONS
4.1 Psoriatic Arthritis Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.3 APAC Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.4 Europe Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024)
5.2 Americas Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
5.3 Americas Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024)
6.2 APAC Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
6.3 APAC Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Psoriatic Arthritis Therapeutics by Country (2019-2024)
7.2 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Psoriatic Arthritis Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PSORIATIC ARTHRITIS THERAPEUTICS MARKET FORECAST
10.1 Global Psoriatic Arthritis Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Psoriatic Arthritis Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Psoriatic Arthritis Therapeutics Forecast
10.1.3 APAC Psoriatic Arthritis Therapeutics Forecast
10.1.4 Europe Psoriatic Arthritis Therapeutics Forecast
10.1.5 Middle East & Africa Psoriatic Arthritis Therapeutics Forecast
10.2 Americas Psoriatic Arthritis Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Psoriatic Arthritis Therapeutics Market Forecast
10.2.2 Canada Psoriatic Arthritis Therapeutics Market Forecast
10.2.3 Mexico Psoriatic Arthritis Therapeutics Market Forecast
10.2.4 Brazil Psoriatic Arthritis Therapeutics Market Forecast
10.3 APAC Psoriatic Arthritis Therapeutics Forecast by Region (2025-2030)
10.3.1 China Psoriatic Arthritis Therapeutics Market Forecast
10.3.2 Japan Psoriatic Arthritis Therapeutics Market Forecast
10.3.3 Korea Psoriatic Arthritis Therapeutics Market Forecast
10.3.4 Southeast Asia Psoriatic Arthritis Therapeutics Market Forecast
10.3.5 India Psoriatic Arthritis Therapeutics Market Forecast
10.3.6 Australia Psoriatic Arthritis Therapeutics Market Forecast
10.4 Europe Psoriatic Arthritis Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Psoriatic Arthritis Therapeutics Market Forecast
10.4.2 France Psoriatic Arthritis Therapeutics Market Forecast
10.4.3 UK Psoriatic Arthritis Therapeutics Market Forecast
10.4.4 Italy Psoriatic Arthritis Therapeutics Market Forecast
10.4.5 Russia Psoriatic Arthritis Therapeutics Market Forecast
10.5 Middle East & Africa Psoriatic Arthritis Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Psoriatic Arthritis Therapeutics Market Forecast
10.5.2 South Africa Psoriatic Arthritis Therapeutics Market Forecast
10.5.3 Israel Psoriatic Arthritis Therapeutics Market Forecast
10.5.4 Turkey Psoriatic Arthritis Therapeutics Market Forecast
10.5.5 GCC Countries Psoriatic Arthritis Therapeutics Market Forecast
10.6 Global Psoriatic Arthritis Therapeutics Forecast by Type (2025-2030)
10.7 Global Psoriatic Arthritis Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Psoriatic Arthritis Therapeutics Product Offered
11.1.3 Pfizer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Psoriatic Arthritis Therapeutics Product Offered
11.2.3 Bayer Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Psoriatic Arthritis Therapeutics Product Offered
11.3.3 Novartis Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Psoriatic Arthritis Therapeutics Product Offered
11.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Psoriatic Arthritis Therapeutics Product Offered
11.5.3 Sanofi Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product Offered
11.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Information
11.7.2 Janssen Biotech Psoriatic Arthritis Therapeutics Product Offered
11.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Janssen Biotech Main Business Overview
11.7.5 Janssen Biotech Latest Developments
11.8 Amgen
11.8.1 Amgen Company Information
11.8.2 Amgen Psoriatic Arthritis Therapeutics Product Offered
11.8.3 Amgen Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Amgen Main Business Overview
11.8.5 Amgen Latest Developments
11.9 UCB
11.9.1 UCB Company Information
11.9.2 UCB Psoriatic Arthritis Therapeutics Product Offered
11.9.3 UCB Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 UCB Main Business Overview
11.9.5 UCB Latest Developments
11.10 AbbVie
11.10.1 AbbVie Company Information
11.10.2 AbbVie Psoriatic Arthritis Therapeutics Product Offered
11.10.3 AbbVie Psoriatic Arthritis Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AbbVie Main Business Overview
11.10.5 AbbVie Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Psoriatic Arthritis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Nonsteroidal Anti-Inflammatory Drug
Table 3. Major Players of Disease-Modifying Antirheumatic Drug
Table 4. Major Players of Biologic Drug
Table 5. Major Players of Enzyme Inhibitor
Table 6. Psoriatic Arthritis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Psoriatic Arthritis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Psoriatic Arthritis Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Psoriatic Arthritis Therapeutics Key Players Head office and Products Offered
Table 15. Psoriatic Arthritis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psoriatic Arthritis Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Psoriatic Arthritis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis Therapeutics
Table 47. Key Market Challenges & Risks of Psoriatic Arthritis Therapeutics
Table 48. Key Industry Trends of Psoriatic Arthritis Therapeutics
Table 49. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Pfizer Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 54. Pfizer Psoriatic Arthritis Therapeutics Product Offered
Table 55. Pfizer Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Bayer Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 59. Bayer Psoriatic Arthritis Therapeutics Product Offered
Table 60. Bayer Main Business
Table 61. Bayer Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bayer Latest Developments
Table 63. Novartis Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 64. Novartis Psoriatic Arthritis Therapeutics Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Latest Developments
Table 68. Abbott Laboratories Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 69. Abbott Laboratories Psoriatic Arthritis Therapeutics Product Offered
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Abbott Laboratories Latest Developments
Table 73. Sanofi Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 74. Sanofi Psoriatic Arthritis Therapeutics Product Offered
Table 75. Sanofi Main Business
Table 76. Sanofi Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Sanofi Latest Developments
Table 78. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 79. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product Offered
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. Janssen Biotech Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 84. Janssen Biotech Psoriatic Arthritis Therapeutics Product Offered
Table 85. Janssen Biotech Main Business
Table 86. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Janssen Biotech Latest Developments
Table 88. Amgen Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 89. Amgen Psoriatic Arthritis Therapeutics Product Offered
Table 90. Amgen Main Business
Table 91. Amgen Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Amgen Latest Developments
Table 93. UCB Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 94. UCB Psoriatic Arthritis Therapeutics Product Offered
Table 95. UCB Main Business
Table 96. UCB Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. UCB Latest Developments
Table 98. AbbVie Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 99. AbbVie Psoriatic Arthritis Therapeutics Product Offered
Table 100. AbbVie Main Business
Table 101. AbbVie Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. AbbVie Latest Developments
Table 1. Psoriatic Arthritis Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Nonsteroidal Anti-Inflammatory Drug
Table 3. Major Players of Disease-Modifying Antirheumatic Drug
Table 4. Major Players of Biologic Drug
Table 5. Major Players of Enzyme Inhibitor
Table 6. Psoriatic Arthritis Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Psoriatic Arthritis Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Psoriatic Arthritis Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Psoriatic Arthritis Therapeutics Key Players Head office and Products Offered
Table 15. Psoriatic Arthritis Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Psoriatic Arthritis Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Psoriatic Arthritis Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Psoriatic Arthritis Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Psoriatic Arthritis Therapeutics
Table 47. Key Market Challenges & Risks of Psoriatic Arthritis Therapeutics
Table 48. Key Industry Trends of Psoriatic Arthritis Therapeutics
Table 49. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Psoriatic Arthritis Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Pfizer Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 54. Pfizer Psoriatic Arthritis Therapeutics Product Offered
Table 55. Pfizer Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Pfizer Main Business
Table 57. Pfizer Latest Developments
Table 58. Bayer Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 59. Bayer Psoriatic Arthritis Therapeutics Product Offered
Table 60. Bayer Main Business
Table 61. Bayer Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Bayer Latest Developments
Table 63. Novartis Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 64. Novartis Psoriatic Arthritis Therapeutics Product Offered
Table 65. Novartis Main Business
Table 66. Novartis Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Novartis Latest Developments
Table 68. Abbott Laboratories Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 69. Abbott Laboratories Psoriatic Arthritis Therapeutics Product Offered
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Abbott Laboratories Latest Developments
Table 73. Sanofi Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 74. Sanofi Psoriatic Arthritis Therapeutics Product Offered
Table 75. Sanofi Main Business
Table 76. Sanofi Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Sanofi Latest Developments
Table 78. Bristol-Myers Squibb Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 79. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Product Offered
Table 80. Bristol-Myers Squibb Main Business
Table 81. Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Bristol-Myers Squibb Latest Developments
Table 83. Janssen Biotech Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 84. Janssen Biotech Psoriatic Arthritis Therapeutics Product Offered
Table 85. Janssen Biotech Main Business
Table 86. Janssen Biotech Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Janssen Biotech Latest Developments
Table 88. Amgen Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 89. Amgen Psoriatic Arthritis Therapeutics Product Offered
Table 90. Amgen Main Business
Table 91. Amgen Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Amgen Latest Developments
Table 93. UCB Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 94. UCB Psoriatic Arthritis Therapeutics Product Offered
Table 95. UCB Main Business
Table 96. UCB Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. UCB Latest Developments
Table 98. AbbVie Details, Company Type, Psoriatic Arthritis Therapeutics Area Served and Its Competitors
Table 99. AbbVie Psoriatic Arthritis Therapeutics Product Offered
Table 100. AbbVie Main Business
Table 101. AbbVie Psoriatic Arthritis Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. AbbVie Latest Developments
LIST OF FIGURES
Figure 1. Psoriatic Arthritis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psoriatic Arthritis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psoriatic Arthritis Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Psoriatic Arthritis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type in 2023
Figure 10. Psoriatic Arthritis Therapeutics in Hospitals
Figure 11. Global Psoriatic Arthritis Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Psoriatic Arthritis Therapeutics in Clinics
Figure 13. Global Psoriatic Arthritis Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Psoriatic Arthritis Therapeutics in Research Labs
Figure 15. Global Psoriatic Arthritis Therapeutics Market: Research Labs (2019-2024) & ($ Millions)
Figure 16. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Psoriatic Arthritis Therapeutics Value Market Share by Country in 2023
Figure 24. United States Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Psoriatic Arthritis Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Psoriatic Arthritis Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Psoriatic Arthritis Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Psoriatic Arthritis Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Psoriatic Arthritis Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Type in 2023
Figure 10. Psoriatic Arthritis Therapeutics in Hospitals
Figure 11. Global Psoriatic Arthritis Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Psoriatic Arthritis Therapeutics in Clinics
Figure 13. Global Psoriatic Arthritis Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Psoriatic Arthritis Therapeutics in Research Labs
Figure 15. Global Psoriatic Arthritis Therapeutics Market: Research Labs (2019-2024) & ($ Millions)
Figure 16. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Psoriatic Arthritis Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Psoriatic Arthritis Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Psoriatic Arthritis Therapeutics Value Market Share by Country in 2023
Figure 24. United States Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Psoriatic Arthritis Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Psoriatic Arthritis Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Psoriatic Arthritis Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Psoriatic Arthritis Therapeutics Market Size Market Share Forecast by Application (2025-2030)
